Add BrightSurf on Google Email

Major progress in curing brain tumours

Researchers at the University of Gothenburg have developed a method to kill glioblastoma brain tumours by blocking stress in cancer cells. The treatment, which involves inserting a specially developed molecule into cells, shows promising results with no side effects.

SourceUniversity of Gothenburg·JournaliScience·TypeExperimental study·DateMay 24, 2023

Combined delivery of engineered virus with immunotherapy is safe and improves outcomes in subset of patients with glioblastoma

A Phase I/II clinical trial combining intratumoral delivery of an engineered oncolytic virus with subsequent immunotherapy improved survival outcomes in a subset of patients with recurrent glioblastoma. The study demonstrated the combination was well-tolerated, with no dose-limiting toxicities.

How cancer genes become independent

A new study has provided insight into the mysterious evolution of DNA rings in tumors, revealing that nearly one-third of all tumors have these genetic structures. The researchers used a technology to trace the path of DNA ring development in neuroblastoma cells, finding that large rings contain cancer genes spurring cell growth.

SourceCharité - Universitätsmedizin Berlin·JournalNature Genetics·DateMay 4, 2023

Hollings team IDs protein that helps cancer cells in cell division process

A research team from the Medical University of South Carolina identified a protein called TACC3 that enables cancer cells to successfully divide despite an abnormality that should lead to their death. This discovery offers new hope for developing targeted therapies to selectively kill cancer cells while leaving normal cells intact.

SourceMedical University of South Carolina·JournalCell Death and Differentiation·DateApr 27, 2023

Cancer cells may sense immune surveillance and actively adapt

Researchers propose a new theory on how cancer cells actively adapt to evade the immune system, losing and gaining tumor-associated antigens. This adaptation makes it difficult for immunotherapies to target cancer cells effectively, but may also create new vulnerabilities that can be therapeutically targeted.

SourceeLife·JournaleLife·DateApr 25, 2023

How cancer evades immune system detection and spreads

Research discovers how cancer cells evade immune system detection and metastasize in the body. Pre-metastatic cells and exhausted CD8+ cells are identified as key players in this process. The study explores ways to target these pathways and activate immune responses to block metastasis.

SourceSingHealth·JournalNature Communications·DateApr 10, 2023

Creating an artificial pathologist

A team of scientists created a new, fast, and precise method for analyzing cells in tissue samples from cancer patients without the need for a trained pathologist. The method uses artificial intelligence to evaluate data produced by a technique called real-time deformability cytometry.

SourceMax-Planck-Gesellschaft·JournalNature Biomedical Engineering·TypeExperimental study·DateApr 8, 2023

Cancer-associated fibroblasts: Challenges and opportunities

Cancer-associated fibroblasts (CAFs) are a type of cell that plays a crucial role in the tumor microenvironment. The authors suggest that understanding CAFs is essential for developing effective cancer therapies. Research targeting CAFs has shown promise, but challenges remain due to their complex nature.

SourceImpact Journals LLC·JournalOncotarget·TypeCommentary/editorial·DateApr 5, 2023

Novel immunotherapy delivery approach safe and beneficial for some melanoma patients with leptomeningeal disease

Researchers at the University of Texas M. D. Anderson Cancer Center have developed a novel approach to administer intrathecal and intravenous immunotherapy to treat leptomeningeal disease (LMD) in melanoma patients, showing promising results in improving survival rates and quality of life for some patients.

Using bacteria to target cancer treatment

Scientists have engineered a unique strain of probiotic bacteria to over-express a metal transporter that binds and concentrates copper, facilitating the delivery of radionuclide therapy to cancer cells. This approach targets tumors without relying on specific receptors, making it potentially effective against treatment-resistant cancers.

SourceUniversity of Cincinnati·JournalAdvanced Healthcare Materials·TypeExperimental study·DateMar 28, 2023

Cellular waste removal differs according to cell type

Researchers at the University of Bonn identified unique features and novel lysosomal proteins in six different cell types, including liver cells and cancer cells. The study provides new insights into cellular waste removal machinery and its role in diseases such as Alzheimer's and Parkinson's.

SourceUniversity of Bonn·JournalMolecular & Cellular Proteomics·TypeExperimental study·DateMar 16, 2023

Oncotarget | Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells

A new review paper suggests that selective protection of normal cells from chemotherapy could increase the therapeutic window and improve outcomes for cancer patients. The authors propose using antagonistic drug combinations to kill drug-resistant cancer cells, reducing side effects and improving quality of life.

SourceImpact Journals LLC·JournalOncotarget·TypeLiterature review·DateMar 13, 2023

Newly identified personalized immunotherapy combination treats an aggressive form of advanced prostate cancer

Researchers discovered a new personalized immunotherapy combination that treats aggressive forms of advanced prostate cancer. By blocking PD-1-expressing macrophages and Wnt/β-catenin pathway activation, the therapy significantly improves response rates in PTEN-deficient cancers.

SourceUniversity of Chicago Medical Center·JournalClinical Cancer Research·TypeExperimental study·DateMar 2, 2023

Researchers discover the mechanism by which tumor cells become resistant to chemotherapy in colorectal cancer

A study published in Nature Communications reveals that platinum accumulates in healthy cells surrounding cancer cells, particularly fibroblasts, and induces gene activation associated with poor response to chemotherapy. Periostin levels serve as a marker of TGF-β activity in fibroblasts and predict treatment benefit.

SUTD researchers developed novel 2D material with virus to kill cancer cells

Scientists from SUTD design a novel thermal-based therapy nano-system that destroys over 20% of pancreatic cancer cells using microsecond electrical pulses, improving cancer cell targeting accuracy and bio-compatibility. The introduction of the M13 virus enhances electro-thermal therapy performance by assembling more on cancer cells.

Addition of antioxidants to cell cultures can enhance the production of monoclonal antibodies, promising therapeutics for a range of health conditions

The addition of antioxidants to cell cultures can improve the production of monoclonal antibodies by reducing oxidative stress and increasing cell viability. This has potential benefits for therapies targeting cancer and autoimmune diseases.

SourceSociety of Chemical Industry·JournalJournal of Chemical Technology and Biotechnology·TypeExperimental study·DateFeb 15, 2023

New cell death mechanism could offer novel cancer treatment strategies

Researchers at the University of Texas MD Anderson Cancer Center have discovered a new cell death mechanism called disulfidptosis that targets cancer cells with high expression of SLC7A11. Disulfidptosis is triggered by glucose starvation and can effectively suppress tumor growth without significant toxicity in normal tissues.

SourceUniversity of Texas M. D. Anderson Cancer Center·JournalNature Cell Biology·TypeExperimental study·DateFeb 6, 2023

The nutrient that cancer cells crave

Researchers found that arginine levels are limited in human cancers, prompting cancer cells to manipulate proteins to take up the amino acid. Starving cancer cells of arginine may lead to mutations that make them more recognizable to the immune system.

SourceRockefeller University·JournalScience Advances·DateFeb 3, 2023

Measuring changes in brain tissue oxygenation for personalized cancer radiotherapy

Researchers developed a method to measure individual biological response to therapy using functional near-infrared spectroscopy, enabling real-time evaluation of radiotherapy's impact on patients. This technique allows for tailored radiation doses to optimize treatment and improve outcomes.

SourceSPIE--International Society for Optics and Photonics·JournalJournal of Biomedical Optics·TypeExperimental study·DateJan 31, 2023

Transforming the way cancer vaccines are designed and made

Researchers developed a new way to increase vaccine potency by changing the structural location of antigens and adjuvants. This approach, called 'rational vaccinology,' allows for precise dosing and tailored presentation of vaccine components, leading to improved immune response and cancer cell targeting.

SourceNorthwestern University·JournalNature Biomedical Engineering·TypeExperimental study·DateJan 31, 2023

A research led from ITEFI-CSIC achieves inhibition of cancer cell migration in vitro after low intensity ultrasound irradiation, allowing a controlled modification of the tumor cells biodynamics without damage

A study led by CSIC demonstrates the efficiency of low-intensity ultrasound therapy in inhibiting cancer cell migration in pancreas cancer models. The researchers successfully controlled tumor cell biodynamics without causing damage.

SourceSpanish National Research Council (CSIC)·JournalFrontiers in Cell and Developmental Biology·DateJan 30, 2023

Tweezers untangle chemotherapeutic’s impact on DNA

Etoposide's impact on DNA structure has been untangled by Cornell researchers using optical tweezers and magnetic tweezers. The study found that etoposide promotes DNA loop trapping and barrier formation by topoisomerase II, enabling the creation of sensitive screening tools for improving patient treatment.

SourceCornell University·JournalNature Chemical Biology·DateJan 30, 2023

Cancer-selective supramolecular chemotherapy by disassembly-assembly approach

Researchers developed a cancer-selective therapeutic agent that targets cancer cells' unique acidic pH microenvironment, inducing mitochondrial dysfunction and killing only cancer cells. The agent, Mito-SA, forms charge-shielded nano-assemblies that selectively disassemble in the tumoral environment.

SourceUlsan National Institute of Science and Technology(UNIST)·JournalAdvanced Functional Materials·DateJan 26, 2023

Chemotherapy in the afternoon dramatically improves treatment outcomes in female lymphoma patients

Researchers found that female patients with diffuse large B-cell lymphoma treated in the afternoon had reduced mortality rates and cancer recurrence compared to those treated in the morning. The study suggests that timing chemotherapy delivery according to an individual's circadian clock may improve treatment outcomes.

SourceInstitute for Basic Science·JournalJCI Insight·TypeRandomized controlled/clinical trial·DateJan 24, 2023

Pusan National University researchers identify therapeutic targets to overcome radioresistance of brain cancer cells

A team of researchers from Korea and USA identified the importance of lipid homeostasis in overcoming brain cancer radioresistance. They found that regulating diacylglycerol kinase B and diacylglycerol acyltransferase 1 could potentially sensitize brain cancer cells to radiotherapy, offering a new treatment strategy.

SourcePusan National University·JournalCell Reports Medicine·TypeExperimental study·DateJan 18, 2023

New molecular blocker halts breast cancer metastasis

Researchers at Bar-Ilan University have discovered a new molecular blocker that successfully halted breast cancer metastasis by targeting the Pyk2 and cortactin interaction. The study's findings provide significant hope for fighting breast cancer, as the blocker inhibited metastasis formation in breast cancer-bearing mice.

SourceBar-Ilan University·JournalOncogene·DateJan 17, 2023